Sasja F. Mulder

Nijmegen, GE, NL 
Nijmegen, GE, NL 

Overview

Sasja Mulder practices practicing medicine in Nijmegen, Netherlands.

Their clinical expertise encompasses Testicular Cancer, Renal Cell Carcinoma (RCC), Ascites, Cystectomy, and Colonoscopy.

They are actively involved in clinical research, co-authoring 32 peer reviewed articles and participating in 2 clinical trials.

Locations

Nijmegen, GE 6525GA, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) With High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors
A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) With High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors
Enrollment Status: Active_not_recruiting
Publish Date: June 16, 2026
Intervention Type: Drug, Procedure
Study Drugs: Paclitaxel, Ifosfamide, Cisplatin, Pegylated G-CSF, G-CSF, Carboplatin, Etoposide Phosphate
Study Phase: Phase 3
A Case-cohort Study to Identify Risk Factors for Cardiovascular Disease in Testicular Cancer Survivors
A Case-cohort Study to Identify Risk Factors for Cardiovascular Disease in Testicular Cancer Survivors
Enrollment Status: Active_not_recruiting
Publish Date: September 15, 2025
Intervention Type: Other
View 1 Less Clinical Trial

32 Total Publications

Etoposide dosing challenges in a testicular cancer patient with hepatic impairment and drug-drug interactions-a case report.
Etoposide dosing challenges in a testicular cancer patient with hepatic impairment and drug-drug interactions-a case report.
Journal: Cancer chemotherapy and pharmacology
Published: December 10, 2025

Frequently Asked Questions about Sasja F. Mulder

Is Sasja F. Mulder a top-rated expert for Testicular Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Sasja F. Mulder is classified as an Experienced expert for Testicular Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sasja F. Mulder participate in research or clinical trials?

Yes. Sasja F. Mulder has published 32 articles and abstracts on conditions like Testicular Cancer. You can view a list of Sasja F. Mulder's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mulder's expertise for a condition
ConditionClose
        View All 7 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile